Test to Treatment: Navigating Positive Blood Culture Syndromic Testing Outcomes.

In this innovation-focused webinar, we’ll explore how syndromic testing is transforming the diagnostic and clinical management of bloodstream infections (BSIs). Featuring real-world experience from the Medical College of Wisconsin, our expert speaker, Nathan Ledeboer, Chief of Clinical Pathology, will share insights into how multiplex syndromic testing is being utilized to accelerate time to diagnosis and guide effective treatment decisions.

Through case studies and clinical data, attendees will gain a deeper understanding of:
• The impact of rapid, multiplex syndromic testing on patient outcomes
• How positive blood culture results are interpreted and acted upon in real clinical workflows
• The role of molecular diagnostics in antimicrobial stewardship and sepsis management

This session is ideal for laboratory professionals, infectious disease specialists, and healthcare leaders looking to optimize their approach to BSI and sepsis diagnostics with smarter, more actionable tools.

Learning Objectives: 

• Identify diagnostic limitations in current BSI management, including gaps in resistance gene detection and challenges with fixed molecular panels.
• Evaluate the potential clinical impact of expanded resistance gene coverage, including detection of emerging threats like SME and MCR, and its role in guiding timely therapeutic decisions.
• Explore real-world scenarios where syndromic testing supports antimicrobial stewardship, such as CRE surveillance, therapy de-escalation, and alignment with antimicrobial stewardship program (ASP) protocols.
• Review of the LIAISON PLEX^® BSI overall performance.